SARS-CoV-2 infection: The role of cytokines in COVID-19 disease

VJ Costela-Ruiz, R Illescas-Montes… - Cytokine & growth factor …, 2020 - Elsevier
COVID-19 disease, caused by infection with SARS-CoV-2, is related to a series of
physiopathological mechanisms that mobilize a wide variety of biomolecules, mainly …

COVID-19: from an acute to chronic disease? Potential long-term health consequences

V Higgins, D Sohaei, EP Diamandis… - Critical reviews in …, 2021 - Taylor & Francis
Abstract Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). Despite pulmonary impairments being the most …

[HTML][HTML] When science goes viral: The research response during three months of the COVID-19 outbreak

J Nowakowska, J Sobocińska, M Lewicki… - Biomedicine & …, 2020 - Elsevier
Here we present the results of a bibliometric survey of peer-reviewed and pre-print papers
published in the English language on issues related to COVID-19 within the first three …

COVID‐19 pathogenesis, prognostic factors, and treatment strategy: Urgent recommendations

B Zhou, S Kojima, A Kawamoto… - Journal of medical …, 2021 - Wiley Online Library
The pandemic of novel coronavirus disease (COVID‐19) is not yet close to being over, more
than 8 months after the first cases, but researchers are making great progress in fighting the …

Coronavirus disease (COVID-19): comprehensive review of clinical presentation

OP Mehta, P Bhandari, A Raut, SEO Kacimi… - Frontiers in Public …, 2021 - frontiersin.org
COVID-19 is a rapidly growing pandemic with its first case identified during December 2019
in Wuhan, Hubei Province, China. Due to the rampant rise in the number of cases in China …

The immune response and immunopathology of COVID-19

E Mortaz, P Tabarsi, M Varahram, G Folkerts… - Frontiers in …, 2020 - frontiersin.org
Coronaviruses were first discovered in the 1960s and are named due to their crown-like
shape. Sometimes, but not often, a coronavirus can infect both animals and humans. An …

Immune response in COVID-19: What do we currently know?

DS Oliveira, NI Medeiros, JAS Gomes - Microbial pathogenesis, 2020 - Elsevier
In 2002/2003 there was a pandemic denominate SARS (severe acute respiratory
syndrome), caused by the SARS-CoV virus that belongs to the genera Betacoranavirus and …

Cellular and molecular pathways of COVID-19 and potential points of therapeutic intervention

JP Hussman - Frontiers in pharmacology, 2020 - frontiersin.org
With the objective of linking early findings relating to the novel SARS-CoV-2 coronavirus
with potentially informative findings from prior research literature and to promote …

The potential similarities of COVID-19 and autoimmune disease pathogenesis and therapeutic options: new insights approach

S Najafi, E Rajaei, R Moallemian, F Nokhostin - Clinical rheumatology, 2020 - Springer
Cytokine pathways and their signaling disorders can be the cause of onset and
pathogenesis of many diseases such as autoimmune diseases and COVID-19 infection …

Macrophage responses associated with COVID-19: A pharmacological perspective

GW Booz, R Altara, AH Eid, Z Wehbe, S Fares… - European Journal of …, 2020 - Elsevier
COVID-19 has caused worldwide death and economic destruction. The pandemic is the
result of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has …